Coronavirus Dialogue Series: Medical Meetings, Post COVID-19

Date: June 17, 2020

Time: 11:00AM - 12:00PM

You must be registered to participate!

1 Clock Hour | Domain A: Strategic Planning 

Medical meetings have mostly cancelled, postponed or have been converted into virtual meetings in 2020 due to the Coronavirus crisis. In recent weeks, many of the our peers are undergoing significant transformations—changing how staffers communicate, adding necessary flexibility in responding and adapting to new demands for meeting formats and styles, cancelling and rescheduling contracts,—all while navigating complex compliance laws and regulations.

Who Should Attend?

  • Corporate medical meeting professionals
  • Healthcare medical meeting professionals
  • Congress organizers
  • Third-party meeting planning companies
  • Procurement professionals
  • Compliance professionals
  • PCO’s
  • DMC’s
  • Hotels
  • Restaurants
  • Destinations
  • CVB’s
  • Other healthcare suppliers

Learning Outcomes: 

  • Participants will learn about updates on the status of medical meetings in the U.S and Europe.
  • Partiticpants will understand changing regulations as a result of the pandemic.
  • Participants will discuss virtual meetings and the rapid release of new technology.
  • Participants will be able to explaing legal disclaimers and new force majeure language.
  • Participants will be able to define the new HCP experience.

This Session Graciously Sponsored by: 

custom image <figure>custom image</figure>
Speaker(s):
  • Pat Schaumann, CMP, CSEP, DMCP, HMCC, President, Schaumann Consulting Group
  • Michael Verlotta, Senior Director, Medical Education, Janssen Biotech
  • Christian-Claus Roth, IPCAA Co-President, Novartis Pharma AG
  • Thomas Reiser, Executive Director, International Society on Thrombosis and Haemostasis
  • John P. Oroho, Life Sciences Compliance Attorney; Executive VP & Chief Strategy Officer, Porzio Life Sciences, LLC
  • Taya Paige, CMM, CIS, HMCC, Strategic Advisor, ITA Group
  • Michael Mahoney, HMCC, Director, Strategic Event Services, Genentech